Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Adultos mayores toman muchas vitaminas, aunque no está demostrado que funcionan
Decenas de estudios han ofrecido “resultados prometedores”, pero nunca pruebas científicas contundentes que muestren que los suplementos vitamínicos previenen enfermedades.
Older Americans Are Hooked On Vitamins Despite Scarce Evidence They Work
Sixty-eight percent of those 65 and older take vitamin supplements. Much of what we once believed about the benefits is wrong.
‘Nightmare Bacteria’ Stalk U.S. Hospitals
The Centers for Disease Control and Prevention found antibiotic-resistant bacteria whose spread has “outpaced” efforts to contain them.
La FDA reducirá la nicotina en cigarrillos, para ayudar a fumadores a dejar el hábito
Autoridades aseguran que este plan ayudará a que los fumadores dejen el hábito, logrará que 33 millones de personas que ahora son menores ni siquiera se acerquen al tabaco, y salvará 8 millones de vidas.
FDA Moves To Cut Nicotine In Cigarettes, Helping Smokers Kick Habit
In a historic move, the Food and Drug Administration stated its intent Thursday to require tobacco companies to cut nicotine levels in their products to make them less addictive. Stripping cigarettes of addictive power could lead an estimated 5 million adults to quit smoking within a year of the plan.
¿Nunca es tarde para operar? Las cirugías al final de la vida son comunes y costosas
Muchos abuelitos se exponen a procedimientos que hacen más mal que bien, afectando su calidad de vida en el poco tiempo que les queda de vida.
Never Too Late To Operate? Surgery Near End Of Life Is Common, Costly
Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.